CRYOPORT, INC. Increase (Decrease) in Deferred Income Taxes
CRYOPORT, INC. (CYRX) reported Increase (Decrease) in Deferred Income Taxes of $8.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2019-03-13
- CRYOPORT, INC. increase (decrease) in deferred income taxes for fiscal 2017 was $8.00M.
| Period end | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|
| 2017-12-31 | $8.00M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |